山羊抗大鼠IgG H&L (DyLight® 488) (ab96887)
Key features and details
- Goat Anti-Rat IgG H&L (DyLight® 488)
- Conjugation: DyLight® 488. Ex: 493nm, Em: 518nm
- Host species: Goat
- Isotype: IgG
- Suitable for: IHC-P, ICC/IF, Flow Cyt
概述
-
产品名称
山羊抗大鼠IgG H&L (DyLight® 488)
参阅全部 IgG 二抗 -
宿主
Goat -
靶标种属
Rat -
特异性
By immunoelectrophoresis and ELISA this antibody reacts specifically with Rat IgG and with light chains common to other Rat immunoglobulins. No antibody was detected against non-immunoglobulin serum proteins. -
经测试应用
适用于: IHC-P, ICC/IF, Flow Cytmore details -
偶联物
DyLight® 488. Ex: 493nm, Em: 518nm
性能
-
形式
Liquid -
存放说明
Shipped at 4°C. Store at +4°C. -
存储溶液
pH: 6.8
Preservative: 0.09% Sodium azide
Constituents: 0.2% BSA, PBS -
Concentration information loading...
-
纯度
Immunogen affinity purified -
纯化说明
This antibody was isolated by affinity chromatography using antigen coupled to agarose beads and conjugated to DyLight® 488. -
克隆
多克隆 -
同种型
IgG -
研究领域
应用
The Abpromise guarantee
Abpromise™承诺保证使用ab96887于以下的经测试应用
“应用说明”部分 下显示的仅为推荐的起始稀释度;实际最佳的稀释度/浓度应由使用者检定。
应用 | Ab评论 | 说明 |
---|---|---|
IHC-P |
1/50 - 1/500.
|
|
ICC/IF |
1/50 - 1/500.
|
|
Flow Cyt |
1/50 - 1/200.
|
说明 |
---|
IHC-P
1/50 - 1/500. |
ICC/IF
1/50 - 1/500. |
Flow Cyt
1/50 - 1/200. |
图片
实验方案
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
数据表及文件
-
Datasheet download
文献 (7)
ab96887 被引用在 7 文献中.
- Castellanos-Montiel MJ et al. An Optimized Workflow to Generate and Characterize iPSC-Derived Motor Neuron (MN) Spheroids. Cells 12:N/A (2023). PubMed: 36831212
- Linzey M et al. Divergent complement system activation in two clinically distinct murine models of multiple sclerosis. Front Immunol 13:924734 (2022). PubMed: 35958570
- Zhang I et al. Nanotherapeutic Modulation of Human Neural Cells and Glioblastoma in Organoids and Monocultures. Cells 9:N/A (2020). PubMed: 33171886
- Ireland L et al. Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer. Oncogene 37:2022-2036 (2018). IHC-P . PubMed: 29367764
- Kulshrestha A et al. Selective inhibition of tumor cell associated Vacuolar-ATPase 'a2' isoform overcomes cisplatin resistance in ovarian cancer cells. Mol Oncol 10:789-805 (2016). PubMed: 26899534
- Jones CI et al. RNA-seq reveals post-transcriptional regulation of Drosophila insulin-like peptide dilp8 and the neuropeptide-like precursor Nplp2 by the exoribonuclease Pacman/XRN1. Nucleic Acids Res 44:267-80 (2016). ICC/IF . PubMed: 26656493
- Lundholm L et al. Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest. Cell Death Dis 4:e478 (2013). Flow Cyt ; Human . PubMed: 23370278